Department of Ophthalmology, Juntendo University Faculty of Medicine, Tokyo, Japan.
PLoS One. 2021 Dec 31;16(12):e0261779. doi: 10.1371/journal.pone.0261779. eCollection 2021.
The coronavirus disease 2019 (COVID-19) pandemic is disturbing and overwhelming a regular medical care in the world. We evaluated the clinical characteristics of patients with primary rhegmatogenous retinal detachment (RRD) during the state of emergency for COVID-19 pandemic in Japan. We also reviewed measures against the COVID-19 pandemic in our institute with a focus on RRD treatment. Retrospectively, patients who underwent initial RRD surgery during the state of emergency between April 7, 2020 and May 25, 2020 were included. For comparison, we recruited patients who underwent surgery for initial RRD during the same period in the last 2 years (2018 and 2019). Data related to the number of surgeries, age, gender, macular detachment, proliferative vitreoretinopathy (PVR), preoperative visual acuity, surgical techniques, the time between the onset and hospitalization and/or surgery of the 2020 cohort were analyzed and compared with those of the 2018 and 2019 cohorts. Furthermore, we reviewed measures taken against COVID-19 in our institute. The number of RRD patients during the state of emergency tended to be lower than that within the last 2 years. Relatively lesser female (vs. male) patients were observed in the 2020 cohort than in the last 2 years (P = 0.084). In contrast, among all cohorts, no significant differences were observed in the incidence of macula-off and PVR, preoperative visual acuity, and the time period between symptom onset and hospitalization and/or surgery. This is the first report to show the clinical patterns of RRD during COVID-19 pandemic in Japan. Despite the state of emergency for the COVID-19 pandemic, no delay in the patient's initial visit to the hospital and surgery was observed. Further studies, including multicenter researches, are important for investigating the influence of COVID-19 on urgent ocular diseases.
2019 年冠状病毒病(COVID-19)大流行扰乱并压倒了全球常规医疗。我们评估了日本 COVID-19 大流行紧急状态期间原发性孔源性视网膜脱离(RRD)患者的临床特征。我们还回顾了我们研究所针对 COVID-19 大流行的措施,重点是 RRD 治疗。回顾性纳入 2020 年 4 月 7 日至 2020 年 5 月 25 日紧急状态期间接受初始 RRD 手术的患者。为了比较,我们招募了在过去 2 年(2018 年和 2019 年)同期接受初始 RRD 手术的患者。分析并比较了 2020 年队列中手术次数、年龄、性别、黄斑脱离、增生性玻璃体视网膜病变(PVR)、术前视力、手术技术、发病至住院和/或手术的时间等数据,与 2018 年和 2019 年队列。此外,我们回顾了我们研究所针对 COVID-19 采取的措施。紧急状态期间 RRD 患者的数量似乎低于过去 2 年。与过去 2 年相比,2020 年队列中观察到的女性(与男性相比)患者相对较少(P = 0.084)。相比之下,在所有队列中,黄斑脱离和 PVR、术前视力以及症状发作至住院和/或手术的时间间隔发生率无显著差异。这是首次报道日本 COVID-19 大流行期间 RRD 的临床模式。尽管 COVID-19 大流行处于紧急状态,但患者首次就诊和手术时间无明显延迟。进一步的研究,包括多中心研究,对于调查 COVID-19 对紧急眼部疾病的影响非常重要。